BPMC - Blueprint Medicines GAAP EPS of -$1.82 beats by $0.22 revenue of $72M beats by $4.9M February, 15 2024 07:10 AM Blueprint Medicines Corporation 2024-02-15 07:10:28 ET More on Blueprint Medicines Blueprint Medicines: Looking Toppy Blueprint Medicines Q4 2023 Earnings Preview Barron’s cites cancer and weight loss plays for biotech M&A Seeking Alpha’s Quant Rating on Blueprint Medicines Historical earnings data for Blueprint Medicines For further details see: Blueprint Medicines GAAP EPS of -$1.82 beats by $0.22, revenue of $72M beats by $4.9M